Abstract
MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) is a mitochondrial disease caused by one or more mutations of tRNALeu(UUR). These mutations reduce both the aminoacylation of tRNALeu(UUR) and a posttranslational modification in the wobble position of tRNALeu(UUR). Both changes result in reduced transcription of mitochondria-encoded proteins; however, reduced aminoacylation affects the decoding of both UUG and UUA while the wobble defect specifically diminishes UUG decoding. Because 12 out of the 13 mitochondria-encoded proteins are more dependent on UUA decoding than UUG decoding, the aminoacylation defect should have a more profound effect on protein synthesis than the wobble defect, which more specifically alters the expression of one mitochondria-encoded protein, ND6. Taurine serves as a substrate in the formation of 5-taurinomethyluridine-tRNALeu(UUR); therefore, taurine deficiency should mimic 5-taurinomethyluridine-tRNALeu(UUR) deficiency. Hence, the wobble hypothesis predicts that the symptoms of MELAS mimic those of taurine deficiency, provided that the dominant defect in MELAS is wobble modification deficiency. On the other hand, if the aminoacylation defect dominates, significant differences should exist between taurine deficiency and MELAS. The present review tests this hypothesis by comparing the symptoms of MELAS and taurine deficiency.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- MELAS:
-
Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes
References
Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, Osame M, Tanaka H (1995) Cardiac involvement in mitochondrial diseases. Circulation 91:955–961
Anderson PA, Baker DH, Corbin JE, Helper LC (1979) Biochemical lesions associated with taurine deficiency in the cat. J Anim Sci 49:1227–1234
Arakawa K, Kudo T, Ikawa M, Morikawa N, Kawai Y, Sahashi K, Lee JD, Kuriyama M, Miyamori I, Okazawa H, Yoneda M (2010) Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to L-arginine infusion. Circ J 74:2702–2711
Azuma J, Sawamura A, Awata N, Hasegawa H, Ogura K, Harada H, Ohta H, Yamauchi K, Kishimoto S (1983) Double-blind randomized crossover trial of taurine in congestive heart failure. Curr Therapeut Res 34:543–557
Bagley PJ, Stipanuk MH (1995) Rats fed a low protein diet supplemented with sulfur amino acids have increased cysteine dioxygenase activity and increased taurine production in hepatocytes. J Nutr 125:933–940
Blondel O, Bailbe D, Portha B (1990) Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment. Metabolism 39:787–793
Chang KJ (2000) Effect of taurine and β-alanine on morphological changes of pancreas in streptozotocin-induced rats. Adv Expt Med Biol 483:571–577
Chiang LM, Jong YJ, Huang SC, Tsai JL, Pang CY, Lee HC, Wei YH (1995) Heteroplasmic mitochondrial DNA mutation in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. J Formos Med Assoc 94:42–47
Davies WE, Harding NJ, Kay IS, Hopkins PC (1994) The role of taurine in mammalian hearing. Adv Expt Biol Med 359:393–398
Gaull GE (1986) Taurine as a conditionally essential nutrient in man. J Am Coll Nutr 5:121–125
Geggel HS, Ament ME, Heckenlively JR, Martin DA, Koppel JD (1985) Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N Engl J Med 312:142–146
Golubnitschaja O, Moenkemann H, Kim K, Mozaffari MS (2003) DNA damage and expression of checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in taurine-deficient cardiomyocytes. Biochem Pharmacol 66:511–517
Han X, Chesney RW (2012) The role of taurine in renal disorders. Amino Acids 43:2249–2263
Hansen SH (2001) The role of taurine in diabetes and the development of diabetic complications. Diabetes/Metabol Res Rev 17:330–346
Harris NG, Plant HD, Inglis BA, Briggs RW, Jones HC (1997) Neurochemical changes in the cerebral cortex of treated and untreated hydrocephalic rat pups quantified with in vitro 1H-NMR spectroscopy. J Neurochem 68:305–312
Hayes KC, Carey RE, Schmidt SY (1975) Retinal degeneration associated with taurine deficiency in the cat. Science 188:949–951
Hayes KC, Stephan ZF, Sturman JA (1980) Growth depression in taurine-depleted infant monkeys. J Nutr 110:2058–2064
Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Haussinger D (2002) Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 16:231–233
Hilton G (1995) MELAS: a mitochondrial encephalomyopathy syndrome. J Neurosci Nurs 27:278–282
Hirano M, Konishi K, Arata N, Iyori M, Saruta T, Kuramochi S, Akizuki M (2002) Renal complications in a patient with A-to-G mutation of mitochondrial DNA at the 3243 position of leucine tRNA. Int Med 41:113–118
Hirano M, Pavlakis SG (1994) Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS): current concepts. J Child Neurol 9:4–13
Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163
Iizuka T, Sakai F (2005) Pathogenesis of stroke-like episodes in MELAS: Analysis of neurovascular cellular mechanisms. Current Neurovasc Res 2:29–45
Imaki H, Moretz R, Wisniewski H, Neuringer M, Sturman J (1987) Retinal degeneration in 3-month-old rhesus monkey infants fed a taurine-free human infant formula. J Neurosci Res 18:602–614
Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927–937
Jacobsen JG, Smith LH Jr (1968) Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48:424–511
Jong CJ, Azuma J, Schaffer S (2012) Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids 42:2223–2232
Kirino Y, Yasukawa T, Ohta S, Akira S, Ishihara K, Watanabe K, Suzuki T (2004) Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci 101:15070–15075
Lake N, de Roode M, Nattel S (1987) Effects of taurine depletion on rat cardiac electrophysiology: in vivo and in vitro studies. Life Sci 40:997–1005
Lake N, Malik N, De Marte L (1988) Taurine depletion leads to loss of rat optic nerve axons. Vision Res 28:1071–1076
Latkany P, Ciulla TA, Cucchillo P, Malkoff MD (1999) Mitochondrial maculopathy: Geographic atrophy of the macula in the MELAS associated A to G 3243 mitochondrial DNA point mutation. Am J Ophthalmol 128:112–114
Maassen JA, Hat LM, van Essen E, Heine RJ, Nijpels G, Tafrechi RSJ, Raap AK, Janssen GMC, Lemkes HHPJ (2004) Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 53(Suppl 1):S103–S109
Maassen JA, Hart LM, Janssen GMC, Reiling E, Romijn JA, Lemkes HH (2006) Mitochondrial diabetes and its lessons for common type 2 diabetes. Biochem Soc Trans 34:819–823
Mozaffari MS, Patel C, Abdelsayad R, Schaffer SW (2006) Accelerated NaCl-induced hypertension in taurine-deficient rat: role of renal function. Renal Int 70:329–337
Mozaffari MS, Tan BH, Lucia MA, Schaffer SW (1986) Effect of drug-induced taurine depletion on cardiac contractility and metabolism. Biochem Pharmacol 35:985–989
Novotny MJ, Hogan PM, Flannigan G (1994) Echocardiographic evidence for myocardial failure induced by taurine deficiency in domestic cats. Can J Vet Res 58:6–12
Novotny MJ, Hogan PM, Paley DM, Adams HR (1991) Systolic and diastolic dysfunction of the left ventricle induced by taurine deficiency in cats. Am J Physiol 261:H121–H127
Oermann E, Warskulat U, Heller-Stilb B, Haussinger D, Zilles K (2005) Taurine-transporter gene knockout-induced changes in GABAA, kainite and AMPA but not NMDA receptor binding in mouse brain. Anat Embryol 210:363–372
Pasantes-Morales H, Arzate ME, Quesada O, Huxtable RJ (1987) Higher susceptibility of taurine-deficient rats to seizures induced by 4-aminopyridine. Neuropharmacology 26:1721–1725
Pion PD, Kittleson MD, Thomas WP, Skiles ML, Rogers QR (1992) Clinical findings in cats with dilated cardiomyopathy and relationship of findings to taurine deficiency. J Am Vet Med Assoc 201:267–274
Pion PD, Kittleson MD, Rogers QR, Morris JG (1987) Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science 237:764–748
Roysommuti S, Suwanich A, Lerdweeraphon W, Thaeomor A, Jirakulsomchok D, Wyss JM (2009) Sex dependent effects of perinatal taurine exposure on the arterial pressure control in adult offspring. Adv Exp Med Biol 643:135–144
Rummelt V, Folberg R, Ionasescu V, Yi H, Moore KC (1993) Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation. Ophthalmology 100:1757–1766
Schaffer SW, Wilson GL (1993) Insulin resistance and mechanical dysfunction in hearts of Wistar rats with streptozotocin-induced non-insulin-dependent diabetes mellitus. Diabetologia 36:195–199
Schmidt SY, Berson EL, Watson G, Huang C (1977) Retinal degeation in cats fed casein III. Taurine deficiency and ERG amplitudes. Invest Ophthalmol Visual Sci 16:673–678
Sergeeva OA, Fleischer W, Chepkova AN, Warskulat U, Haussinger D, Siebler M, Hess HL (2007) GABAA–receptor modification in taurine transporter knockout mice causes striatal disinhibition. J Physiol 585:539–548
Silbert L, Durocher A, Biller J (1996) The “S” in MELAS. J Stroke Cerebrovasc Dis 6:67–71
Smith PR, Bain SC, Good PA, Hattersley AT, Barnett AH, Gibson JM, Dodson PM (1999) Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNALeu A to G mutation. Ophthalmology 106:1101–1108
Sproule DM, Kaufmann P (2008) Mitochondrial encephalopathy, lactic acidosis and strokelike episodes: Basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 1142:133–158
Sproule DM, Kaufmann P, Engelstad K, Starc TJ, Hordof AJ, DeVivo DC (2007) Wolff-Parkinson-White syndrome in patients with MELAS. Arch Neurol 64:1625–1627
Sue CM, Crimmins DS, Soo YS, Pamphlett R, Presgrave CM, Kotsimbos N, Jean-Francois MJB, Byrne E, Morris JGL (1998) Neuroradiological features of six kindreds with MELAS tRNALeu A3243G point mutation: implications for pathogenesis. J Neurl Neurosug Psychiatry 65:233–240
Thambisetty M, Newman NJ, Glass JD, Frankel MR (2002) A practical approach to the diagnosis and management of MELAS: case report and review. Neurologist 8:302–312
Trachtman H, Barbour R, Sturman JA, Finberg L (1988) Taurine and osmoregulation: Taurine is a cerebral osmoprotective molecular in chronic hypernatremic dehydration. Pediatr Res 23:35–39
Trachtman H, Del Pizzo R, Futterweit S, Levine D, Rao PS, Valderrama E, Sturman JA (1992) Taurine attenuates renal disease in chronic puromycin aminonucleoside nephropathy. Am J Physiol 262:F117–F123
Turnbull HE, Lax NZ, Diodato D, Ansorge O, Turnbull DM (2010) The mitochondrial brain: From mitochondrial genome to neurodegeneration. Biochim Biophys Acta 1802:111–121
Tyson JE, Lasky R, Flood D, Mize C, Picone T, Paule CL (1989) Randomized trial of taurine supplementation for infants < 1,300-gram birth weight: effect on auditory brainstem-evoked responses. Pediatrics 83:406–415
Vallecalle-Sandoval MH, Heaney G, Sersen E, Sturman JA (1991) Comparison of the developmental changes of the brainstem auditory evoked response (BAER) in taurine-supplemented and taurine-deficient kittens. Int J Dev Neurosci 9:571–579
Van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PAA, van de Kamp JJP, Maaseen JA (1992) Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368–371
Vinton NE, Heckenlively JR, Laidlaw SA, Martin DA, Foxman SR, Ament ME, Kopple JD (1990) Visual function in patients undergoing long-term total parenteral nutrition. Am J Clin Nutr 52:895–902
Vionnet N, Passa P, Froguel P (1993) Prevalence of mitochondrial gene mutations in families with diabetes mellitus. Lancet 342:1429–1430
Warskulat U, Borsch E, Reinehr R, Heller-Stilb B, Monnighoff I, BuchczykD DM, Flogel U, Kappert G, Soboll S, Beer S, Pfeffer K, Marschall HU, Gabrielsen M, Amiry-Moghaddam M, Ottersen OP, Dienes HP, Haussinger D (2006) Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEB J 20:574–576
Warskulat U, Flogel U, Jacoby C, Harwig HG, Thewissen M, Merx MW, Molojavyi A, Heller-Stilb B, Schrader J, Haussinger D (2004) Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J 18:577–579
Weiss C, Glowatzki E, Fuchs P (2009) The postsynaptic function of type II cochlear afferents. Nature 461:1126–1129
Wen GY, Sturman JA, Wisniewski HM, Lidsky AA, Cornwell AC, Hayes KC (1979) Tapetum disorganization in taurine-depleted cats. Invst Opthalmol Visual Sci 18:1200–1206
Yasukawa T, Suzuki T, Suzuki T, Ueda T, Ohta S, Watanabe K (2000) Modification defect at anticodon wobble nucleotide of mitochondrial tRNAsLeu(UUR) with pathogenic mutations of mitochondrila myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J Biol Chem 275:4251–4257
Yatabe Y, Miyakawa S, Miyazaki T, Matsuzaki Y, Ochiai N (2003) Effects of taurine administration in rat skeletal muscles on exercise. J Orthop Sci 8:415–419
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this paper
Cite this paper
Schaffer, S.W., Jong, C.J., Warner, D., Ito, T., Azuma, J. (2013). Taurine Deficiency and MELAS Are Closely Related Syndromes. In: El Idrissi, A., L'Amoreaux, W. (eds) Taurine 8. Advances in Experimental Medicine and Biology, vol 776. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6093-0_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6093-0_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6092-3
Online ISBN: 978-1-4614-6093-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)